Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03146221

Search for Restenosis Markers in Lower Limb Arteritis

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The initial hypothesis of this work is that the genesis and the evolution of the atheromatous plaque are partly controlled at the molecular level and in particular by the microRNAs through their role as regulator of the genes. The study of the tissue and serum profile over time of specific microRNAs involved in the regulation of atheromatous plaque correlated with clinical data and restenosis imaging will allow to define biological markers of restenosis in the patient with an arteritis of the lower limbs . This study is a pioneer in the field and it would be imprudent to conclude that a biomarker would be used clinically at the end of this work alone. Nevertheless this study will make a major advance in this topic, in vivo intervention studies with inhibition or over-expression of microRNA will obviously be necessary to confirm the use of these as biomarkers of arteritis of the lower limbs. Regular assay of reliable biomarkers in arterial patients will ultimately suggest early management to best adapt surgical and medical treatment.

Conditions

Interventions

TypeNameDescription
OTHERTo look for serum microRNA profiles associated with restenosisTo look for serum microRNA profiles associated with restenosis

Timeline

Start date
2017-06-20
Primary completion
2020-06-20
Completion
2020-06-20
First posted
2017-05-09
Last updated
2017-07-21

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03146221. Inclusion in this directory is not an endorsement.